DRUG · Unmapped registry intervention
Docetaxel plus lonafarnib
Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
NCT00539968
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Breast Cancerverified · MONDO: breast cancer
Ovarian Cancerverified · MONDO: ovarian cancer
Lung Cancerverified · MONDO: lung cancer
Gastric Cancerverified · MONDO: gastric cancer
Interventions
Sponsors & collaborators
Merck Sharp & Dohme LLClead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00539968 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.